No paradigm changes with checkpoint inhibitor monotherapy in patients with metastatic renal cell carcinoma and brain metastases

Ann Transl Med. 2019 Nov;7(22):612. doi: 10.21037/atm.2019.11.50.
No abstract available

Publication types

  • Editorial
  • Comment